Meyka Pro banner
ADR120S, Inc.

ADR120S, Inc. Fundamental Analysis (JPX: 3750.T)

3750.TJPX
HealthcareBiotechnology
¥775.00
¥12.00(1.57%)
Japanese Market opens in 10h 48m

ADR120S, Inc. Fundamental Analysis (JPX: 3750.T)

ADR120S, Inc. (JPX: 3750.T) shows weak financial fundamentals with a PE ratio of -12.28, profit margin of -5.46%, and ROE of -6.59%. The company generates $0.1B in annual revenue with weak year-over-year growth of -58.28%.

Key Strengths

PEG Ratio-1.14

Areas of Concern

ROE-6.59%
Operating Margin-8.44%
Cash Position0.97%
We analyze 3750.T's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -1066.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-1066.5/100

We analyze 3750.T's fundamental strength across five key dimensions:

Efficiency Score

Weak

3750.T struggles to generate sufficient returns from assets.

ROA > 10%
-1.54%

Valuation Score

Excellent

3750.T trades at attractive valuation levels.

PE < 25
-12.28
PEG Ratio < 2
-1.14

Growth Score

Moderate

3750.T shows steady but slowing expansion.

Revenue Growth > 5%
-58.28%
EPS Growth > 10%
81.45%

Financial Health Score

Excellent

3750.T maintains a strong and stable balance sheet.

Debt/Equity < 1
-3.49
Current Ratio > 1
1.10

Profitability Score

Weak

3750.T struggles to sustain strong margins.

ROE > 15%
-658.83%
Net Margin ≥ 15%
-5.46%
Positive Free Cash Flow
No

Key Financial Metrics

Is 3750.T Expensive or Cheap?

P/E Ratio

3750.T trades at -12.28 times earnings. This suggests potential undervaluation.

-12.28

PEG Ratio

When adjusting for growth, 3750.T's PEG of -1.14 indicates potential undervaluation.

-1.14

Price to Book

The market values ADR120S, Inc. at -96.02 times its book value. This may indicate undervaluation.

-96.02

EV/EBITDA

Enterprise value stands at -7.74 times EBITDA. This is generally considered low.

-7.74

How Well Does 3750.T Make Money?

Net Profit Margin

For every $100 in sales, ADR120S, Inc. keeps $-5.46 as profit after all expenses.

-5.46%

Operating Margin

Core operations generate -8.44 in profit for every $100 in revenue, before interest and taxes.

-8.44%

ROE

Management delivers $-6.59 in profit for every $100 of shareholder equity.

-6.59%

ROA

ADR120S, Inc. generates $-1.54 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.54%

Following the Money - Real Cash Generation

Operating Cash Flow

ADR120S, Inc. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.

$0.00

Free Cash Flow

ADR120S, Inc. generates weak or negative free cash flow of $0.00, restricting financial flexibility.

$0.00

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

3750.T converts 0.00% of its market value into free cash.

0.00%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-12.28

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-1.14

vs 25 benchmark

P/B Ratio

Price to book value ratio

-96.02

vs 25 benchmark

P/S Ratio

Price to sales ratio

67.11

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-3.49

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.10

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-6.59

vs 25 benchmark

ROA

Return on assets percentage

-1.54

vs 25 benchmark

ROCE

Return on capital employed

-18.13

vs 25 benchmark

How 3750.T Stacks Against Its Sector Peers

Metric3750.T ValueSector AveragePerformance
P/E Ratio-12.2832.14 Better (Cheaper)
ROE-658.83%550.00% Weak
Net Margin-546.29%30133.00% Weak
Debt/Equity-3.490.56 Strong (Low Leverage)
Current Ratio1.105.70 Neutral
ROA-154.29%3.00% Weak

3750.T outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews ADR120S, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-96.63%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

56.26%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

-767.82%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ